Ignite Creation Date:
2025-12-25 @ 12:56 AM
Ignite Modification Date:
2026-01-01 @ 3:20 PM
Study NCT ID:
NCT05660967
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-02
First Post:
2022-11-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Subcutaneous Epcoritamab With or Without Lenalidomide as First Line Therapy for Diffuse Large B-Cell Lymphoma
Sponsor:
Genmab
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-03-06
Start Date Type:
ACTUAL
Primary Completion Date:
2026-01-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-07-31
Completion Date Type:
ESTIMATED
First Submit Date:
2022-11-29
First Submit QC Date:
None
Study First Post Date:
2022-12-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-01
Last Update Post Date:
2025-12-02
Last Update Post Date Type:
ESTIMATED